Effectiveness and safety of switching to biosimilar infliximab and etanercept in patients with psoriasis
Sign Up to like & getrecommendations! Published in 2019 at "Dermatologic Therapy"
DOI: 10.1111/dth.12846
Abstract: Real-life data on the effectiveness and safety of biosimilar and biologic drugs licensed for treatment of psoriasis is lacking. We retrospectively analysed patient records from 69 patients with moderate to severe psoriasis treated at the… read more here.
Keywords: effectiveness safety; biosimilar infliximab; safety; infliximab etanercept ... See more keywords